Importance of cytotoxic T lymphocytes in the rejection of transplanted hepatocellular carcinoma.
Fischer rats became resistant to syngeneic hepatocellular carcinoma (FAA-HTC1) cells on repeated sensitization with mitomycin C-treated FAA-HTC1 cells. In contrast, FAA-HTC1 cells injected into the liver killed normal control Fischer rats within 2 months. Histopathological studies revealed massive accumulation of mononuclear cells in the tumor tissues of sensitized rats that rejected syngeneic FAA-HTC1 cells, whereas very few mononuclear cells were found in the tumor tissues of control rats. Cell populations infiltrating the tumor tissues were identified by flow cytometric analysis. Mononuclear cells found within the regressing tumors of the sensitized rats were identified as mostly T cells, and two-thirds of these T cells were CD8-positive. Compared with the activity in control rats, the killer activity of mononuclear cells infiltrating tumors was significantly increased in the sensitized rats 7 days after tumor inoculation. Depletion of CD8(+) T cells significantly reduced the cytotoxicity of mononuclear cells infiltrating tumors obtained from sensitized rats. In contrast, depletion of CD16(+) cells reduced the cytotoxicity of mononuclear cells infiltrating tumors obtained from both control and sensitized rats. Furthermore, the CD16(+) cell-depleted fraction of mononuclear cells infiltrating tumors showed significant cytotoxicity against FAA-HTC1 cells, but failed to show cytotoxicity against other syngeneic tumor cells or allogeneic hepatoma cells.
Kohda
H
H
Third Department of Internal Medicine, Asahikawa Medical College, Japan.
Sekiya
C
C
Torimoto
Y
Y
Mizuno
M
M
Fujimoto
Y
Y
Tanaka
T
T
Matsumoto
A
A
Murazumi
Y
Y
Ohhira
M
M
Hasebe
C
C
D000818:Animals; D016827:CD8 Antigens / Q000032:analysis; D005434:Flow Cytometry; D006084:Graft Rejection / Q000276:immunology*; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008114:Liver Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D008297:Male; D016685:Mitomycin / Q000494:pharmacology; D009368:Neoplasm Transplantation / Q000276:immunology; D051381:Rats; D011916:Rats, Inbred F344; D017452:Receptors, IgG / Q000032:analysis; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D016827:CD8 Antigens; D017452:Receptors, IgG; D016685:Mitomycin